1,1-dichloroethene increases expression ISO RGD:1312540 6480464 vinylidene chloride results in increased expression of SH3GLB1 mRNA CTD PMID:26682919 17alpha-ethynylestradiol multiple interactions ISO RGD:1312540 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SH3GLB1 mRNA CTD PMID:17942748 17beta-estradiol decreases expression ISO RGD:1312540 6480464 Estradiol results in decreased expression of SH3GLB1 mRNA CTD PMID:22467019 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1312539 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1312540 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SH3GLB1 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SH3GLB1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1312540 6480464 Tetrachlorodibenzodioxin affects the expression of SH3GLB1 mRNA CTD PMID:21570461 2,4,6-tribromophenol increases expression ISO RGD:1312539 6480464 2 more ... CTD PMID:31675489 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of SH3GLB1 mRNA CTD PMID:21346803 2-hydroxypropanoic acid increases expression ISO RGD:1312539 6480464 Lactic Acid results in increased expression of SH3GLB1 mRNA CTD PMID:30851411 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:1312539 6480464 tetrabromobisphenol A results in increased expression of SH3GLB1 protein CTD PMID:31675489 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1312540 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of SH3GLB1 mRNA CTD PMID:26251327 3,4-methylenedioxymethamphetamine decreases methylation ISO RGD:1312540 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased methylation of SH3GLB1 promoter CTD PMID:26251327 4,4'-sulfonyldiphenol increases methylation ISO RGD:1312540 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of SH3GLB1 exon CTD PMID:33297965 4,4'-sulfonyldiphenol increases expression ISO RGD:1312539 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of SH3GLB1 protein CTD PMID:34186270 4-hydroxyphenyl retinamide decreases expression ISO RGD:1312540 6480464 Fenretinide results in decreased expression of SH3GLB1 mRNA CTD PMID:28973697 aflatoxin B1 decreases expression ISO RGD:1312540 6480464 Aflatoxin B1 results in decreased expression of SH3GLB1 mRNA CTD PMID:19770486 all-trans-retinoic acid increases expression ISO RGD:1312539 6480464 Tretinoin results in increased expression of SH3GLB1 mRNA CTD PMID:23724009 antirheumatic drug increases expression ISO RGD:1312539 6480464 Antirheumatic Agents results in increased expression of SH3GLB1 mRNA CTD PMID:24449571 Aroclor 1254 decreases expression ISO RGD:1312540 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of SH3GLB1 mRNA CTD PMID:23650126 atazanavir sulfate increases expression ISO RGD:1312539 6480464 Atazanavir Sulfate results in increased expression of SH3GLB1 mRNA CTD PMID:32152650 atazanavir sulfate multiple interactions ISO RGD:1312539 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA CTD PMID:32152650 benzo[a]pyrene decreases expression ISO RGD:1312540 6480464 Benzo(a)pyrene results in decreased expression of SH3GLB1 mRNA CTD PMID:19770486 benzo[a]pyrene increases methylation ISO RGD:1312539 6480464 Benzo(a)pyrene results in increased methylation of SH3GLB1 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1312539 6480464 Benzo(a)pyrene results in increased expression of SH3GLB1 mRNA CTD PMID:26238291 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SH3GLB1 mRNA CTD PMID:25181051 , PMID:30816183 bisphenol A increases expression ISO RGD:1312539 6480464 bisphenol A results in increased expression of SH3GLB1 protein CTD PMID:34186270 bisphenol A decreases expression ISO RGD:1312539 6480464 bisphenol A results in decreased expression of SH3GLB1 protein CTD PMID:31675489 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SH3GLB1 mRNA CTD PMID:34947998 bisphenol A decreases methylation ISO RGD:1312540 6480464 bisphenol A results in decreased methylation of SH3GLB1 promoter CTD PMID:27312807 Bisphenol B increases expression ISO RGD:1312539 6480464 bisphenol B results in increased expression of SH3GLB1 protein CTD PMID:34186270 calcitriol multiple interactions ISO RGD:1312539 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of SH3GLB1 mRNA CTD PMID:21592394 calcitriol increases expression ISO RGD:1312539 6480464 Calcitriol results in increased expression of SH3GLB1 mRNA CTD PMID:21592394 carbamazepine affects expression ISO RGD:1312539 6480464 Carbamazepine affects the expression of SH3GLB1 mRNA CTD PMID:24752500 chenodeoxycholic acid multiple interactions ISO RGD:1312539 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA more ... CTD PMID:32152650 cisplatin increases expression ISO RGD:1312540 6480464 Cisplatin results in increased expression of SH3GLB1 mRNA CTD PMID:21151649 clofibrate decreases expression ISO RGD:1312540 6480464 Clofibrate results in decreased expression of SH3GLB1 mRNA CTD PMID:17585979 cobalt dichloride increases expression ISO RGD:1312539 6480464 cobaltous chloride results in increased expression of SH3GLB1 mRNA CTD PMID:19376846 copper(II) sulfate increases expression ISO RGD:1312539 6480464 Copper Sulfate results in increased expression of SH3GLB1 mRNA CTD PMID:19549813 cyclosporin A decreases expression ISO RGD:1312540 6480464 Cyclosporine results in decreased expression of SH3GLB1 mRNA CTD PMID:19770486 cyclosporin A multiple interactions ISO RGD:1312539 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA CTD PMID:32152650 cyclosporin A increases expression ISO RGD:1312539 6480464 Cyclosporine results in increased expression of SH3GLB1 mRNA CTD PMID:20106945 more ... decabromodiphenyl ether increases expression ISO RGD:1312539 6480464 decabromobiphenyl ether results in increased expression of SH3GLB1 protein CTD PMID:31675489 deguelin increases expression ISO RGD:1312539 6480464 deguelin results in increased expression of SH3GLB1 mRNA CTD PMID:33512557 deoxycholic acid multiple interactions ISO RGD:1312539 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA more ... CTD PMID:32152650 diazinon affects expression EXP 6480464 Diazinon affects the expression of SH3GLB1 mRNA CTD PMID:22546817 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of SH3GLB1 mRNA CTD PMID:21266533 diclofenac affects expression ISO RGD:1312539 6480464 Diclofenac affects the expression of SH3GLB1 mRNA CTD PMID:24752500 dioxygen increases expression ISO RGD:1312540 6480464 Oxygen deficiency results in increased expression of SH3GLB1 mRNA CTD PMID:22629407 dioxygen multiple interactions ISO RGD:1312540 6480464 Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of SH3GLB1 mRNA] CTD PMID:22629407 doxorubicin decreases expression ISO RGD:1312540 6480464 Doxorubicin results in decreased expression of SH3GLB1 mRNA CTD PMID:26873546 doxorubicin affects expression ISO RGD:1312539 6480464 Doxorubicin affects the expression of SH3GLB1 protein CTD PMID:29385562 enniatin decreases expression EXP 6480464 enniatins results in decreased expression of SH3GLB1 mRNA CTD PMID:27163883 enzyme inhibitor multiple interactions ISO RGD:1312539 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SH3GLB1 protein CTD PMID:23301498 epoxiconazole increases expression ISO RGD:1312540 6480464 epoxiconazole results in increased expression of SH3GLB1 mRNA CTD PMID:35436446 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of SH3GLB1 mRNA CTD PMID:24136188 folic acid decreases expression ISO RGD:1312540 6480464 Folic Acid results in decreased expression of SH3GLB1 mRNA CTD PMID:25629700 glycochenodeoxycholic acid multiple interactions ISO RGD:1312539 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA more ... CTD PMID:32152650 glycocholic acid multiple interactions ISO RGD:1312539 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA more ... CTD PMID:32152650 glycodeoxycholic acid multiple interactions ISO RGD:1312539 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA more ... CTD PMID:32152650 ivermectin decreases expression ISO RGD:1312539 6480464 Ivermectin results in decreased expression of SH3GLB1 protein CTD PMID:32959892 leflunomide increases expression ISO RGD:1312539 6480464 leflunomide results in increased expression of SH3GLB1 mRNA CTD PMID:28988120 , PMID:29427785 methyl methanesulfonate increases expression ISO RGD:1312539 6480464 Methyl Methanesulfonate results in increased expression of SH3GLB1 mRNA CTD PMID:23649840 nefazodone increases expression ISO RGD:1312539 6480464 nefazodone results in increased expression of SH3GLB1 mRNA CTD PMID:32152650 nefazodone multiple interactions ISO RGD:1312539 6480464 [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA CTD PMID:32152650 oxybenzone increases expression EXP 6480464 oxybenzone results in increased expression of SH3GLB1 mRNA CTD PMID:30316929 paracetamol increases expression ISO RGD:1312539 6480464 Acetaminophen results in increased expression of SH3GLB1 mRNA CTD PMID:25704631 , PMID:29067470 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1312540 6480464 [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of SH3GLB1 mRNA CTD PMID:36331819 perfluorooctanoic acid increases expression ISO RGD:1312539 6480464 perfluorooctanoic acid results in increased expression of SH3GLB1 protein CTD PMID:26879310 phenobarbital affects expression ISO RGD:1312539 6480464 Phenobarbital affects the expression of SH3GLB1 mRNA CTD PMID:19159669 phenylmercury acetate increases expression ISO RGD:1312539 6480464 Phenylmercuric Acetate results in increased expression of SH3GLB1 mRNA CTD PMID:26272509 piroxicam decreases expression ISO RGD:1312539 6480464 Piroxicam results in decreased expression of SH3GLB1 mRNA CTD PMID:21858171 rac-lactic acid increases expression ISO RGD:1312539 6480464 Lactic Acid results in increased expression of SH3GLB1 mRNA CTD PMID:30851411 resveratrol multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of SH3GLB1 mRNA CTD PMID:25905778 rotenone increases expression EXP 6480464 Rotenone results in increased expression of SH3GLB1 mRNA CTD PMID:28374803 silver atom decreases expression ISO RGD:1312540 6480464 Silver results in decreased expression of SH3GLB1 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1312540 6480464 Silver results in decreased expression of SH3GLB1 mRNA CTD PMID:27131904 sodium arsenate increases expression ISO RGD:1312540 6480464 sodium arsenate results in increased expression of SH3GLB1 mRNA CTD PMID:21795629 Soman increases expression EXP 6480464 Soman results in increased expression of SH3GLB1 mRNA CTD PMID:19281266 streptozocin multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of SH3GLB1 mRNA CTD PMID:25905778 succimer multiple interactions ISO RGD:1312540 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SH3GLB1 mRNA CTD PMID:21641980 sunitinib increases expression ISO RGD:1312539 6480464 Sunitinib results in increased expression of SH3GLB1 mRNA CTD PMID:31533062 tert-butyl hydroperoxide decreases expression ISO RGD:1312539 6480464 tert-Butylhydroperoxide results in decreased expression of SH3GLB1 mRNA CTD PMID:15336504 testosterone multiple interactions ISO RGD:1312539 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of SH3GLB1 mRNA CTD PMID:21592394 testosterone increases expression ISO RGD:1312539 6480464 Testosterone results in increased expression of SH3GLB1 mRNA CTD PMID:21592394 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of SH3GLB1 gene CTD PMID:27618143 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of SH3GLB1 mRNA CTD PMID:30589522 triptonide increases expression ISO RGD:1312540 6480464 triptonide results in increased expression of SH3GLB1 mRNA CTD PMID:33045310 valproic acid decreases expression ISO RGD:1312539 6480464 Valproic Acid results in decreased expression of SH3GLB1 mRNA CTD PMID:23179753 valproic acid affects expression ISO RGD:1312539 6480464 Valproic Acid affects the expression of SH3GLB1 mRNA CTD PMID:25979313 valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of SH3GLB1 mRNA CTD PMID:29427782